Dublin/Ireland: ERS Genomics announced today that the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (“PTAB”) confirmed that its decision regarding priority of invention between the Broad Institute and the University of California, the University of Vienna, and Emmanuelle Charpentier (collectively, CVC) was focused on single-guide CRISPR/Cas9 systems in eukaryotic cells, and has […]
We are glad to announce that we have reached a settlement with Organovo in which we agreed to resolve all aspects of the disputes between the parties. Organovo and BICO were engaged in several legal disputes regarding Organovo’s patents. Under the new agreement, all civil actions regarding potential infringements and IPRs concerning validity of Organovo’s patents are […]
SAN JOSE, Calif. — Takara Bio USA, Inc. (TBUSA) today announced that the European Patent Office has reviewed and confirmed the validity of TBUSA’s granted European patent EP 3105325, entitled “Methods of depleting a target molecule from an initial collection of nucleic acids, and compositions and kits for practicing the same.” TBUSA’s patent was opposed […]
LEHIGH ACRES, Fla. — EXpressLO LLC is the most comprehensive provider of focused ion beam (FIB) ex situ lift out (EXLO) specimen preparation solutions for transmission electron microscopy (EM) and other analytical techniques. As of January 27, 2022, EXpressLO LLC submitted a patent application to the U.S. Patent and Trademark Office describing highly innovative methods and apparatus for […]
Almelo, The Netherlands – Malvern Panalytical Inc. and TA Instruments-Waters LLC have agreed to a partial settlement of Malvern Panalytical’s patent infringement lawsuit against TA. Malvern Panalytical sued TA Instruments-Waters LLC and its parent company Waters Technology Corporation (collectively “TA”) in 2019 for alleged infringement of five Malvern Panalytical U.S. patents. The parties agreed to […]
Due to recently filed counterclaims in patent lawsuit by Organovo, Inc., (“Organovo”) to the Federal Court in Delaware, BICO Group AB (“BICO”) releases the following statement to explain the background and context. BICO, CELLINK and all our group companies respect valid intellectual property and believe that Organovo’s patent claims at issue are invalid, not infringed, […]
SAN DIEGO — Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in Delaware court in 2021. At issue in this lawsuit is whether Cellink is infringing Organovo patents. Organovo, as one of the earliest and most prominent 3D bioprinting companies, has built […]
We are pleased to see that the jury invalidated the claim of United States Patent No. 7,541,444 asserted by Illumina in the trial in the Northern District of California. This patent contained the broadest of all the asserted claims and had the longest remaining life of the five asserted patents. With this result, MGI may potentially […]
Company Filed Second Patent Application to Extend Core Technology Applications MURRIETA, Calif. — Murrieta Genomics is pleased to announce that U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its subsidiary simplSEQ’ s patent application No. 17/331,532 for certain claims related to the isolation and immobilization of nucleic acids and uses thereof. This novel approach to […]
Company Filed Second Patent Application to Extend Core Technology Applications MURRIETA, Calif. — Murrieta Genomics is pleased to announce that U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its subsidiary simplSEQ’ s patent application No. 17/331,532 for certain claims related to the isolation and immobilization of nucleic acids and uses thereof. This novel approach to […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
